SCHEMBL30729546

SCHEMBL30729546

C#CC1C[C@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PPM1D O15297 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179161 1.00 PPM1D (0.32) PPM1D
SCHEMBL27274686 0.86 MAPT (0.35) PPM1D
SCHEMBL27179170 0.86 MAPT (0.35) PPM1D
SCHEMBL31234770 0.86 MAPT (0.35) PPM1D
SCHEMBL22367426 0.86 DPP4 (0.39) PPM1D
SCHEMBL5183988 0.85 HSD17B10 (0.33) —
SCHEMBL5120279 0.85 HSD17B10 (0.33) —
SCHEMBL31234561 0.85 HSD17B10 (0.33) —
SCHEMBL30861987 0.85 HSD17B10 (0.33) —
SCHEMBL31234179 0.83 PPM1D (0.31) PPM1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220532-A1 PYRROLIDINE KRAS INHIBITORS INCYTE CORPORATION (US) 2024-10-24 — — WO disclosed
WO-2024015731-A1 FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS INCYTE CORPORATION (US) 2024-01-18 — — WO disclosed
Send feedback